SNU-620 Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | SNU-620 cells are a human gastric carcinoma cell line established from malignant ascites of an adult patient with poorly differentiated adenocarcinoma. They are part of a panel of gastric cancer cell lines developed to represent diverse histopathological and biological characteristics of gastric tumors. In vitro, SNU-620 cells exhibit a scattered growth pattern with heterogeneous cell distribution and limited attachment to culture substrates, reflecting their origin from a poorly differentiated tumor with minimal desmoplasia. Morphologically, the cells display predominantly round-to-oval contours with a relatively low nuclear-to-cytoplasmic ratio and poorly developed microvilli, as observed through ultrastructural analysis. SNU-620 cells contribute to the study of gastric cancer biology through their expression of tumor-associated antigens and molecular alterations characteristic of gastric malignancies. Broader characterization of related SNU gastric cancer lines revealed frequent mutations in key oncogenes and tumor suppressors, including p53, highlighting their relevance for investigating genetic instability and oncogenic signaling pathways in gastric carcinoma. These features make SNU-620 cells a useful in vitro model for studies on tumor progression, metastasis, and therapeutic response in gastric cancer. |
|---|---|
| Organism | Human |
| Tissue | Metastatic |
| Disease | Gastric adenocarcinoma |
| Metastatic site | Ascites |
| Synonyms | SNU620, NCI-SNU-620 |
Characteristics
| Age | 59 years |
|---|---|
| Gender | Female |
| Ethnicity | Korean |
| Growth properties | Suspension |
Regulatory Data
| Citation | SNU-620 (Cytion catalog number 305910) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_5079 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | None |
| Doubling time | 31 hours |
| Seeding density | 0.1 to 1 x 106 /ml |
| Freeze medium | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Metastatic site: | Ascites |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305910-090226 | Certificate of Analysis | 05. Mar. 2026 | 305910 |